Becker's Hospital Review

September 2019 Becker's Hospital Review

Issue link: https://beckershealthcare.uberflip.com/i/1161749

Contents of this Issue

Navigation

Page 27 of 83

PUT PATIENTS ON THEIR TREATMENT TRACK FROM DAY 1 With one injection of ARISTADA INITIO and a single dose of oral aripiprazole plus ARISTADA 1064 mg, you can fully dose on day 1 for 2 months of treatment. 1,2 ARISTADA IS PROVEN EFFECTIVE IN THE TREATMENT OF ADULT PATIENTS WITH SCHIZOPHRENIA Please visit AnLAIoption.com/beckers and see full Prescribing Information, including Boxed Warning, for ARISTADA INITIO and ARISTADA for complete dosing and administration instructions. Please see Important Safety Information, including Boxed Warning, for ARISTADA INITIO and ARISTADA. Please see additional Important Safety Information on the following page. WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. ARISTADA INITIO and ARISTADA are not approved for the treatment of patients with dementia-related psychosis. INDICATION ARISTADA INITIO® (aripiprazole lauroxil), in combination with oral aripiprazole, is indicated for the initiation of ARISTADA® (aripiprazole lauroxil) when used for the treatment of schizophrenia in adults. ARISTADA is indicated for the treatment of schizophrenia in adults. IMPORTANT SAFETY INFORMATION •  The first and only 2-month dose (1064 mg) for schizophrenia 2 •  ARISTADA® (aripiprazole lauroxil) can be started without prior treatment with monthly long-acting injectables after the patient has demonstrated tolerability to oral aripiprazole 2 • Consider ARISTADA for your appropriate adult patients with schizophrenia 2

Articles in this issue

Links on this page

view archives of Becker's Hospital Review - September 2019 Becker's Hospital Review